First, TRPV6 deficiency attenuates corticosterone-induced intestinal mucosal permeability, TJ and AJ disruption, endotoxemia, systemic inflammation, and liver damage. This evidence concerns the gene TRPV6 and serum lipopolysaccharide activity.